A simple Genetic test could help to improve colon cancer screening
According to a recent research published in journal The New England Journal of Medicine states that a simple non-invasive test including detection of the genetic abnormalities can effectively relate to cancer and further it could help to improve the effectiveness of colon cancer screening treatment.
The study conducted by comparison of two types of tests that required screening colorectal cancer. First a non-invasive, multitarget stool test that included DNA markers in relation to colon cancer and finds stool blood and other test a commercial fecal immunochemical test. Later it was found that first test proved helpful in improving the colon cancer screening.
David Ransohoff, MD, professor of medicine at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center member explains, “Detection of 92 percent of colon cancer is extremely high for a non-invasive test, so that a negative test result means that no further evaluation, like colonoscopy, is needed at that time. Having such a sensitive, non-invasive option could have an important effect on screening rates for colorectal cancer.”